| Successful kidney transplantation after COVID-19 #MMPMID32706459Varotti G; Dodi F; Garibotto G; Fontana ITranspl Int 2020[Oct]; 33 (10): 1333-1334 PMID32706459show ga
ä|*Kidney Transplantation[MESH]|Adult[MESH]|Antibodies, Viral/blood[MESH]|Bacteremia/complications[MESH]|Basiliximab/adverse effects/therapeutic use[MESH]|COVID-19 Testing[MESH]|COVID-19/*complications/diagnosis[MESH]|Combined Modality Therapy[MESH]|Escherichia coli Infections/complications[MESH]|Female[MESH]|Glomerulonephritis, Membranous/complications[MESH]|Graft Rejection/prevention & control[MESH]|Humans[MESH]|Hypertension/complications[MESH]|Immunocompromised Host[MESH]|Immunosuppressive Agents/adverse effects/therapeutic use[MESH]|Kidney Failure, Chronic/*complications/surgery/therapy[MESH]|Nasopharynx/virology[MESH]|Postoperative Complications[MESH]|Prednisone/adverse effects/therapeutic use[MESH]|Renal Dialysis[MESH]|SARS-CoV-2/immunology/*isolation & purification[MESH]
DeepDyve Pubget Overpricing |
|